Jacobs Levy Equity Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-56,192
| Closed | -$6.43M | – | 1130 |
|
|
2020
Q3 | $6.43M | Buy |
56,192
+46,137
| +459% | +$5.28M | 0.07% | 288 |
|
|
2020
Q2 | $1.13M | Buy |
+10,055
| New | +$1.13M | 0.01% | 645 |
|
|
2017
Q1 | – | Sell |
-8,240
| Closed | -$1.01M | – | 1044 |
|
|
2016
Q4 | $1.01M | Buy |
+8,240
| New | +$1.01M | 0.02% | 552 |
|
|
2015
Q3 | – | Sell |
-74,266
| Closed | -$13.4M | – | 885 |
|
|
2015
Q2 | $13.4M | Sell |
74,266
-74,543
| -50% | -$13.5M | 0.26% | 130 |
|
|
2015
Q1 | $25.8M | Buy |
148,809
+34,777
| +30% | +$6.03M | 0.44% | 65 |
|
|
2014
Q4 | $21.1M | Buy |
114,032
+8,663
| +8% | +$1.6M | 0.36% | 80 |
|
|
2014
Q3 | $17.5M | Buy |
105,369
+103,437
| +5,354% | +$17.2M | 0.29% | 117 |
|
|
2014
Q2 | $302K | Sell |
1,932
-188,237
| -99% | -$29.4M | 0.01% | 712 |
|
|
2014
Q1 | $28.9M | Buy |
190,169
+170,879
| +886% | +$26M | 0.48% | 56 |
|
|
2013
Q4 | $2.56M | Sell |
19,290
-49,170
| -72% | -$6.53M | 0.04% | 390 |
|
|
2013
Q3 | $7.95M | Buy |
68,460
+50,150
| +274% | +$5.83M | 0.13% | 201 |
|
|
2013
Q2 | $1.69M | Buy |
+18,310
| New | +$1.69M | 0.03% | 456 |
|